BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34404682)

  • 1. Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software.
    Mariotto AB; Zhang F; Buckman DW; Miller D; Cho H; Feuer EJ
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2001-2009. PubMed ID: 34404682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Cancer Survival Trends by Updated Summary Stage.
    Forjaz G; Ries L; Devasia TP; Flynn G; Ruhl J; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1508-1517. PubMed ID: 37623930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
    Pulte D; Gondos A; Brenner H
    Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016.
    Lewis DR; Siembida EJ; Seibel NL; Smith AW; Mariotto AB
    Cancer; 2021 Nov; 127(22):4277-4286. PubMed ID: 34308557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the Life Expectancy of Patients with Cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing improvement in outcomes for patients diagnosed as having Non-Hodgkin lymphoma from the 1990s to the early 21st century.
    Pulte D; Gondos A; Brenner H
    Arch Intern Med; 2008 Mar; 168(5):469-76. PubMed ID: 18332290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
    Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
    Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
    Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
    Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.
    Brunner AM; Campigotto F; Sadrzadeh H; Drapkin BJ; Chen YB; Neuberg DS; Fathi AT
    Cancer; 2013 Jul; 119(14):2620-9. PubMed ID: 23625575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
    Miranda MB; Lauseker M; Kraus MP; Proetel U; Hanfstein B; Fabarius A; Baerlocher GM; Heim D; Hossfeld DK; Kolb HJ; Krause SW; Nerl C; Brümmendorf TH; Verbeek W; Fauser AA; Prümmer O; Neben K; Hess U; Mahlberg R; Plöger C; Flasshove M; Rendenbach B; Hofmann WK; Müller MC; Pfirrmann M; Hochhaus A; Hasford J; Hehlmann R; Saußele S
    Leukemia; 2016 Jun; 30(6):1255-62. PubMed ID: 26859076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
    Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
    BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
    Găman AM; Dobrea C; Rotaru I
    Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
    Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
    Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial/ethnic, age and sex disparities in leukemia survival among adults in the United States during 1973-2014 period.
    Utuama O; Mukhtar F; Pham YT; Dabo B; Manani P; Moser J; Michael-Asalu A; Tran CT; Le LC; Le TV; Vu KT; Park JY; Boffetta P; Zheng W; Shu XO; Luu HN
    PLoS One; 2019; 14(8):e0220864. PubMed ID: 31425527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
    Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
    Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing between proliferating nodal lymphoid blasts in chronic myelogenous leukemia and non-Hodgkin lymphoma: report of three cases and detection of a bcr/abl fusion signal by single-cell analysis.
    Yashima-Abo A; Satoh T; Abo T; Aoki Y; Kowata S; Ito S; Ishida Y; Fujiwara H; Maesawa C; Masuda T
    Pathol Int; 2005 May; 55(5):273-9. PubMed ID: 15871725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.